9. The method according to claim 8 , further comprising: establishing a drug efficacy score on the basis of a drug's efficacy towards a defined therapeutic endpoint for each of the plurality of substantially similar drugs; and ranking the plurality of substantially similar drugs on the basis of the drug efficacy score and a prevalence criteria determined by the prevalence of use of a particular drug within the prescribing entity's practice.
9. The method according to claim 8 , further comprising: establishing a drug efficacy score on the basis of a drug's efficacy towards a defined therapeutic endpoint for each of the plurality of substantially similar drugs; and ranking the plurality of substantially similar drugs on the basis of the drug efficacy score and a prevalence criteria determined by the prevalence of use of a particular drug within the prescribing entity's practice. 10. The method according to claim 9 , further comprising: comparing the safety and efficacy score of a drug being marketed against the safety and efficacy scores of the plurality; identifying particular ones of the drugs commonly prescribed by the prescribing entity that exhibit lower safety and/or efficacy scores from the drug being marketed; and identifying those drug-drug and/or drug-disease interactions for which the drug being marketed exhibits superior scores than the drugs commonly prescribed by the prescribing entity.